Yahoo! Finance: Top Stories

Madrigal Pharmaceuticals Closer to EU Approval for First MASH Treatment, Rezdiffra

Jun 24, 2025 - 18:06
 0
Madrigal Pharmaceuticals Closer to EU Approval for First MASH Treatment, Rezdiffra
Read More

Tags:

Previous Article

Managing Crisis Communications: Edelman Smithfield Managing Director Ira Gorsky,...

Next Article

Argenx Secures EC Approval for Subcutaneous VYVGART in CIDP Treatment

Related Posts

S&P 500 Rises as Fed-Cut Bets Sink Treasury Yields: Markets Wrap

S&P 500 Rises as Fed-Cut Bets Sink Treasury Yields: Mar...

May 15, 2025  0

Home Sales Rose in May, but Housing Market Is Still Sluggish

Home Sales Rose in May, but Housing Market Is Still Slu...

Jun 24, 2025  0

Gold Sinks as Dollar Posts Stronger Day

Gold Sinks as Dollar Posts Stronger Day

Jun 5, 2025  0